To view the PDF file, sign up for a MySharenet subscription.

UBS AG - Finalisation of results and name change relating to the Extraordinary Resolution for UBS ZAR Automatic Early Redeemable Notes UBS007

Release Date: 20/11/2026 15:00
Code(s): UBS007     PDF:  
Wrap Text
Finalisation of results and name change relating to the Extraordinary Resolution for UBS ZAR Automatic Early Redeemable Notes UBS007

UBS AG, London Branch
(“UBS AG” or the “Company”)
(Incorporated and domiciled in Switzerland)
(Registration number: CHE-101.329.561)

ALPHA CODE:          UBS007
ISIN:                ZAE000366175

Finalisation of results and name change relating to the Extraordinary
Resolution for UBS ZAR Automatic Early Redeemable Notes linked to the S&P
500 Index, FTSE 100 Index, Euro STOXX 50 Index and the Nikkei 225 Index, due
2031 (the “Notes”)

1.    Introduction

1.1   Noteholders are referred to the notice announced via SENS on 16 October
      2026 to all the outstanding Noteholders regarding consent to approve
      the proposed Final Terms and replace them with a further amended and
      restated Final Terms by passing the Written Resolution.

1.2   Noteholders’ consent was requested by Written Resolution in terms of
      Condition 15.2 of the General Terms and Conditions of the Notes,
      whereby a majority (not less than 75%) of the outstanding number of
      issued Notes (excluding Notes held by the Issuer) is required to pass
      the Extraordinary Resolution.

1.3   As per the announcement via SENS dated 16 October 2026, voting closed
      on Friday 20 November 2026 at 12:00 midday. The amendments to the
      Final Terms for the Notes have been approved by Noteholders, based on
      the results shown below, and will take effect from Friday, 04 December
      2026.

2.    Results

Notes in issue by holder:
 Total number of issued Notes (unitised)                      400,000   100%
 Total number of Notes held by the Issuer (unitised)          315,448    79%
 Total number of Notes held by Noteholders (unitised)          84,552    21%

Results of the voting by Noteholders are as follows:
 Extraordinary Resolution Number 1 of the
 Noteholders of all outstanding Notes –                     Number   Percent
 Amendments to Final Terms                              (unitised)       (%)
 For                                                        84,552      100%
 Against                                                        0         0%
 Abstain                                                        0         0%
 Total                                                      84,552      100%

3.    Important Dates and Times

Important salient dates relating to the changes to the description of the
JSE Product long name:

Expected last day (LDT) on which the
existing Product Long Name will be displayed    Monday, 30 November 2026
(old Product Long Name: UBS UBS007 21Jul31)

Expected first day (ex-date) on which the
new Product Long Name will be displayed       Tuesday, 01 December 2026
(new Product Long Name: UBS UBS007 22Jul31)

Record Date                                   Thursday, 03 December 2026

Accounts of dematerialised securities
                                              Friday, 04 December 2026
holders updated by CSDPs / Brokers


Noteholders are advised that the ISIN, alpha code, short name, underlying
indices, and existing holdings will remain unchanged. The change to the
Product Long Name does not create a new security and Noteholders are not
required to sell or repurchase their Notes as a result of the name change.

For further information regarding the Notice of written resolution and/or
the Notes, please contact:

UBS KeyInvest South Africa
Tel.: +27 11 322 7129 / 7865
E-mail: keyinvestza@ubs.com
Web: http://keyinvest-za.ubs.com

Johannesburg
20 November 2026

Sponsor: UBS South Africa (Pty) Limited
Date: 20/11/2026 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.